1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Simon F, Caumes E, Jelinek T, Lopez-Velez R, Steffen R, Chen LH.

    Chikungunya: risks for travellers

    JOURNAL OF TRAVEL MEDICINE . 30(2): . Number of citations: 3

    [doi:10.1093/jtm/taad008]

  • Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I.

    Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . : . Number of citations: 1

    [doi:10.1093/jac/dkad102]

  • Saavedra C, Vallejo A, Longo F, Serrano JJ, Fernández M, Gion M, López-Miranda E, Martínez-Jáñez N, Guerra E, Chamorro J, Rosero D, Velasco H, Martín A, Carrato A, Casado JL, Cortés A.

    Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors

    Cancers . 15(7): . Number of citations: 1

    [doi:10.3390/cancers15072000]

  • Kolossváry M, deFilippi C, McCallum S, Fitch KV, Diggs MR, Fulda ES, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Malvestutto CD, Currier JS, Casado JL, Gutiérrez F, Sereti I, Douglas PS, Zanni MV, Grinspoon SK.

    Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.

    EBioMedicine . 90: 104538-104538.

    [doi:10.1016/j.ebiom.2023.104538]

  • Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Bouza E.

    Insights for COVID-19 in 2023.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 36(2): 114-124. Number of citations: 4

    [doi:10.37201/req/122.2022]

  • Pérez Molina JA, Crespillo-Andújar C, Zamora J, Fernández-Félix BM, Gaetano-Gil A, López-Bernaldo de Quirós JC, Serrano-Villar S, Moreno S, Álvarez-Díaz N, Berenguer J.

    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.

    CLINICAL INFECTIOUS DISEASES . 76(11): 2027-2037.

    [doi:10.1093/cid/ciad177]

  • Ron R, Moreno E, Martínez-Sanz J, Brañas F, Sainz T, Moreno S, Serrano-Villar S.

    CD4/CD8 ratio during HIV treatment: time for routine monitoring?

    CLINICAL INFECTIOUS DISEASES . 76(9): 1688-1696. Number of citations: 1

    [doi:10.1093/cid/ciad136]

  • Úbeda M, Maza MDC, Delgado P, Horndler L, Abia D, García-Bermejo L, Serrano-Villar S, Calvo C, Bastolla U, Sainz T, Fresno M.

    Diversity of immune responses in children highly exposed to SARS-CoV-2.

    Frontiers in immunology . 14: 1105237-1105237.

    [doi:10.3389/fimmu.2023.1105237]

  • Escudero-Sánchez R, Rubio Martín E, Vizcarra P, Braojos Sánchez F, Diaz Gago Á, Del Campo Albendea L, Muriel A, Halperin A, Ponce Alonso M, Moreno Guillén S, Cobo J.

    Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78(3): 823-827.

    [doi:10.1093/jac/dkad019]

  • Schnittman SR, Kitch DW, Swartz TH, Burdo TH, Fitch KV, McCallum S, Flynn JM, Fulda ES, Diggs MR, Stapleton JT, Casado JL, Taron J, Currier JS, Zanni MV, Malvestutto C, Fichtenbaum CJ, Aberg JA, Ribaudo HJ, Lu MT, Douglas PS, Grinspoon SK.

    Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.

    Open forum infectious diseases . 10(3): .

    [doi:10.1093/ofid/ofad106]

  • Núñez-Pereira S, Benavent E, Ulldemolins M, Sobrino-Díaz B, Iribarren JA, Escudero-Sánchez R, Del Toro MD, Nodar A, Sorli L, Bahamonde A, Vilchez HH, Gasch O, Muñez E, Rodríguez-Montserrat D, García-País MJ, Haddad S, Sellarès-Nadal J, Murillo O, Rodríguez-Pardo D, On Behalf Of Geio-Seimc Group For The Study Of Osteoarticular Infections-Spanish.

    Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study

    ANTIBIOTICS-BASEL . 12(3): .

    [doi:10.3390/antibiotics12030518]

  • Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, Sojo-Dorado J, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Reguera JM, Valiente de Santis L, Torre-Cisneros J, Cano Á, Roilides E, Radulovic L, Kirakli C, Shaw E, Falagas ME, Pintado V, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodriguez-Baño J.

    Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA)

    Eclinicalmedicine . 57: 101871-101871. Number of citations: 8

    [doi:10.1016/j.eclinm.2023.101871]

  • Fernández-Ruiz M, Bodro M, Gutiérrez Martín I, Rodriguez-Álvarez R, Ruiz-Ruigómez M, Sabé N, López-Viñau T, Valerio M, Illaro A, Fortún J, Salto-Alejandre S, Cordero E, Fariñas MDC, Muñoz P, Vidal E, Carratalà J, Goikoetxea J, Ramos-Martínez A, Moreno A, Aguado JM.

    Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation . 107(3): 762-773. Number of citations: 3

    [doi:10.1097/TP.0000000000004312]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Blasco M, Grandal-Platero M, Haemmerle J, Fernández-Escribano M, Vallejo A.

    Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.

    VIRUSES-BASEL . 15(3): . Number of citations: 1

    [doi:10.3390/v15030627]

  • de Gea-Grela A, Moreno S.

    Controversies in the Design of Strategies for the Cure of HIV Infection.

    PATHOGENS . 12(2): . Number of citations: 1

    [doi:10.3390/pathogens12020322]

  • Fortún J, Mateos M, de la Pedrosa EG, Soriano C, Pestaña D, Palacios J, López J, Moreno S, Covid-Team.

    Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection

    JOURNAL OF FUNGI . 9(2): . Number of citations: 3

    [doi:10.3390/jof9020130]

  • De La Torre-Tarazona E, González-Robles A, Cascajero A, Jiménez P, Miró JM, Sánchez-Palomino S, Alcamí J, Buzón MJ, García-Pérez J.

    Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV

    JOURNAL OF MEDICAL VIROLOGY . 95(2): .

    [doi:10.1002/jmv.28543]

  • Moreno E, Ron R, Serrano-Villar S.

    The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causation.

    Frontiers in immunology . 14: 1072655-1072655.

    [doi:10.3389/fimmu.2023.1072655]